Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
e5fmebG4PhsxFYwq
Listen
